This unique course touches upon the radiobiological, radiochemical and dosimetric aspects in the development of radiopharmaceuticals.
The training course will be organized at SCK CEN (Mol, Belgium) from 20 to 24 March 2023.
For more information visit the SCK CEN website.
We are pleased to share with you the TEDx conference that Sarah Baatout (SCK CEN) recently gave in Namur under the title “Mon rayon: la radiorésistance”, in which she presented SCK CEN's main research in the field of medicine, radiopharmaceuticals, and space. Enjoy!
The current cut-off date is 30 September 2022. Hearings with all user projects passing the eligibility threshold will take place on 2 November 2022.
The project application consists of two parts:
For practical information on preparing and submitting a proposal for the PRISMAP user calls, please refer to our guide for applicants.
You can also find the answers to the most frequently asked questions about PRISMAP services in our FAQ page.
And do not hesitate to contact us through our Helpdesk if you want to discuss the feasibility of your project.
We look forward to receiving your projects!
Interested contributors have until 30 September 2022 to submit abstracts for the IAEA’s International Symposium on Trends in Radiopharmaceuticals (ISTR-2023), to be held from 17 to 21 April 2023 at the IAEA headquarters in Vienna, Austria.
The Symposium will bring together (radio)chemists, (radio)pharmacists, biologists, physicists, technologists, medical researchers, policy makers, health regulators, educators, and other professionals working in the fields of production and uses of medical radioisotopes and radiopharmaceuticals.
Discussion topics will include challenges and opportunities in the development, production and uses of diagnostic, therapeutic and theranostic radioisotopes and radiopharmaceuticals, and regulatory and licensing issues. Discussions will also cover current needs in terms of continuous education in radiopharmaceutical sciences, and certification and training methodologies for radiopharmacists.
Attendance at the conference is free of charge and there is no registration fee.
For more information: https://www.iaea.org/events/istr-2023
We are very pleased to announce that we have included a Frequently Asked Questions (FAQ) page on the PRISMAP website.
Here you can find answers to the most frequently asked questions about PRISMAP services.
We hope you find this page useful!
This time, our consortium meeting was held in the wonderful city of Riga.
It was a fantastic occasion to exchange ideas, discuss project developments, and connect with the PRISMAP community.
Thank you all for making our CM3 a great success!
Our PRISMAP public event on 15 June 2022 was a great success!
More than 70 participants from all over the world, testimonials from project users, and very interesting discussions.
Thank you all for your participation!
Join our PRISMAP User Forum to receive information about our next events and newsletter: https://www.prismap.eu/radionuclides/user-forum/
Do you hold a PhD in physics and have a strong knowledge of experimental nuclear physics? ILL is recruiting a Nuclear Physicist to work in the “Nuclear and Particle Physics (NPP)” group.
For more information please refer to the job announcement.
CERN is recruting an experimental program coordinator for MEDICIS and PRISMAP.
For more information please refer to the job announcement.
The 1st call of PRISMAP has come to an end. After a few months of receiving proposals, evaluating the projects, and holding hearings, 9 projects have been selected for funding.
Here is where they came from:
You can find the summary of the PRISMAP user projects here: https://www.prismap.eu/access/user-projects/
The radiobiology unit of SCK CEN, Mol, Belgium is looking for a research project leader to contribute to the research on the effects of radiation therapy on human health with a particular focus on the central nervous and cardiovascular systems. This project leader will participate in radiation-induced health research development of strategies to identify and implement (novel) sensitive technologies for assessing disease initiation and long-term health effects as well as (individual) responses to radiation therapy.
PRISMAP believes in gender equality, diversity, and inclusion. That is why 42% of the PRISMAP consortium is made up of women, and we have included the role of the Diversity Vanguard, as part of our Coordination Team, to ensure diversity and inclusion in our project.
We will continue to take action against stereotypes and discrimination.
Happy International Women's Day!
This education seminar is organised by the PRISMAP standards and harmonisation group and will give insight in the many components needed to better understand translating novel non-conventional radionuclides into radiopharmaceuticals for clinical application.
Events page: https://www.prismap.eu/event/
In 2020 EURADOS published an update of its Strategic Research Agenda (SRA). The updated SRA contains 5 visions which cover the main fields in radiation dosimetry. For each vision challenges and subsequently more detailed research lines are defined. Vision 4: “Towards integrated personalized dosimetry in medical applications” covers the challenges of patient dosimetry in nuclear medicine focussing on both internal dosimetry for pre-clinical development and evaluation of radiopharmaceuticals emitting alpha, beta and auger radiation and implementation of internal dosimetry in clinical practice. Based on SRA vision 4, EURADOS Working Group 7 “internal dosimetry” composes a task group focussing on the development of a roadmap towards a dosimetry model for radionuclide therapy which should provide guidance on the role of EURADOS to address internal dosimetry for therapeutic radiopharmaceuticals.
To attend: https://www.bigmarker.com/sckcen/EURADOS-webinar-January-2022